Delivery Order SPE2DB22D3301-SPE2DB24FY1CG
Award Date
2/20/24
Potential Completion Date
2/21/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The potential value of this order is $1,761.66, with a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $1,071.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply KONVOMEP 2-84 MG/ML oral suspension (90 ml). This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the government to efficiently procure a comprehensive range of medical commodities to support military...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 300ML. The contract has a ceiling value of $1,770.95 and a period of performance ending on March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $7,100.48 firm-fixed-price contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a completion date of July 29, 2024 and was awarded on July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a potential value of $1,428.00 and a completion date of February 1, 2024. The contract does not have a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,975.26, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,693.15 firm fixed-price delivery order is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,530.00, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen Drug Corp is a for-profit organization that holds several Indefinite...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a ceiling value of $2,965.91 and a performance period through January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $4,393.65, is for the delivery of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...